Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Non-Intensive Continuous Treatment with a Tyrosine Kinase Inhibitor (TKI) Followed By Allo-HSCT Is an Effective Therapeutic Strategy for Adult Ph-Positive Acute Lymphoblastic Leukemia: Outcomes of the Russian Prospective Multicenter RALL Study

Olga A. Gavrilina, Elena N. Parovichnikova, Vera V. Troitskaya, Zalina Kh. Akhmerzaeva, Sergey N. Bondarenko, Valery A. Lapin, Maria E. Grishunina, Olga S. Samoylova, Tatiana S. Konstantinova, Larisa A. Kuzmina, Julia A. Chabaeva, Valery G. Savchenko

Blood (2021) 138 (Supplement 1): 4395.

https://doi.org/10.1182/blood-2021-153068

Published: 2021

Journal Articles

Dynamics of Cytokines Concentration in the Blood Plasma of Patients after Multipotent Mesenchymal Stromal Cells Administration for Graft Versus Host Disease Prevention

Nataliya A. Petinati, Julia O Davydova, Kseniya A. Nikiforova, Alexey Bigildeev, Georgiy Arapidi, Nina J. Drize, Larisa A. Kuzmina, Elena N. Parovichnikova, Valeriy G. Savchenko

Blood (2021) 138 (Supplement 1): 1101.

https://doi.org/10.1182/blood-2021-144552

Published: 2021

Journal Articles

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Natalia N. Popova, MD, Vera A. Vasilyeva, MD PhD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Olga S. Starikova, MD, Ulyana V. Maslikova, MD, Maria V. Dovydenko, MD PhD, Ekterina Usikova, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 1987.

https://doi.org/10.1182/blood-2019-126822

Published: 2019

Journal Articles

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Zoya V. Konova, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Julia O. Davydova, Mikhail Yu. Drokov, MD PhD, Maria V. Nareyko, MD, Natalia N. Popova, MD, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Ekaterina I. Usikova, MD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Vera A. Vasilyeva, MD PhD, Tatiana I. Lobanova, MD, Larisa A. Kuzmina, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 4562.

https://doi.org/10.1182/blood-2019-123528

Published: 2019

Journal Articles

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

Maria V. Dovydenko, MD PhD, Elena N. Parovichnikova, MD PhD, Larisa A. Kuzmina, MD PhD, Vera A. Vasilyeva, MD PhD, Mikhail Yu. Drokov, MD PhD, Olga M. Koroleva, MD, Ekaterina D. Mikhaltsova, MD PhD, Natalia N. Popova, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Tatiana V. Gaponova, MD PhD, Denis V. Kamelskih, MD, Michael Maschan, MDMSc, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5648.

https://doi.org/10.1182/blood-2019-131316

Published: 2019

Journal Articles

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy

Maxim V. Solovev, MD, Larisa P. Mendeleeva, MD PhD Prof, Olga S. Pokrovskaya, MD PhD, Eduard G. Gemdzhian, PhD, Larisa A. Kuzmina, MD PhD, Maiia V. Firsova, Maria V. Nareyko, MD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3294.

https://doi.org/10.1182/blood.V130.Suppl_1.3294.3294

Published: 2017

Journal Articles

Chemotherapy Related Neuropsychological Changes in Patients with Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia

Sergei Khrushchev, MS, PhD, Dmitry Vybornykh, MD PhD, Lada Olexenko, Alexandra Nesterova, Alexander Tkhostov, Prof. Dr., Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5647.

https://doi.org/10.1182/blood.V130.Suppl_1.5647.5647

Published: 2017

Journal Articles

Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

Ekaterina Mikhaltsova, MD, Mikhail Yu. Drokov, MD PhD, Julia O. Davydova, Larisa A. Kuzmina, MD PhD, Natalia Popova, MD, Daria Dubnyak, MD, Vera Vasilyeva, MD, Olga Koroleva, MD, Zoya Konova, MD, Nikolay M. Kapranov, Irina V. Galtseva, MD PhD, Elena N. Parovichnikova, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5485.

https://doi.org/10.1182/blood.V130.Suppl_1.5485.5485

Published: 2017

Journal Articles

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma

Maiia V. Firsova, Larisa P. Mendeleeva, MD PhD Prof, Alla M. Kovrigina, MD PhD, Olga S. Pokrovskaya, MD PhD, Natalia L. Deineko, MD, Maxim V. Solovev, MD, Maria V. Nareyko, MD, Larisa A. Kuzmina, MD PhD, Eduard G. Gemdzhian, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5358.

https://doi.org/10.1182/blood.V130.Suppl_1.5358.5358

Published: 2017

Journal Articles

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Nataliya Petinati, PhD MD, Nikolay M. Kapranov, Yuliya O Davydova, Alexey Bigildeev, PhD, Natalia Sats, PhD, Irina Shipounova, PhD, Nina Drize, PhD, Irina V. Galtseva, MD PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5494.

https://doi.org/10.1182/blood.V130.Suppl_1.5494.5494

Published: 2017

Journal Articles

Intraosseous Administration of Multipotent Mesenchymal Stromal Cells to Patients with Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation

Nataliya Petinati, PhD MD, Natalia Sats, PhD, Nina Drize, PhD, Natalia Risinskaya, Andrey Sudarikov, Maya Firsova, MD PhD, Natalia Popova, MD, Daria Dubnyak, MD, Olga Koroleva, MD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5475.

https://doi.org/10.1182/blood.V130.Suppl_1.5475.5475

Published: 2017

Journal Articles

Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Julia O. Davydova, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Vera Vasilyeva, MD, Daria Dubnyak, MD, Olga Koroleva, MD, Ekaterina Mikhaltsova, MD, Natalia Popova, MD, Zoya Konova, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 1990.

https://doi.org/10.1182/blood.V130.Suppl_1.1990.1990

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Andrey N. Sokolov, MD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, Sergei M. Kulikov, PhD, Sergey N. Bondarenko, PhDMD, Julia O. Davidova, Nikolay M. Kapranov, Irina A. Lukyanova, MD, Tatiana I. Lobanova, MD, Ekaterina I. Usikova, MD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3884.

https://doi.org/10.1182/blood.V130.Suppl_1.3884.3884

Published: 2017

Journal Articles

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Anna A. Sidorova, MD, Gennadii M. Galstian, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Anton Olenev, Olga Korobitsyna, Alexandr Korobkin, MD, Elena Kirillova, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 4665.

https://doi.org/10.1182/blood.V130.Suppl_1.4665.4665

Published: 2017

Journal Articles

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Sergey N. Bondarenko, PhDMD, Valery Lapin, Tatiana N. Obukhova, MD PhD, Andrey Sudarikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 2714.

https://doi.org/10.1182/blood.V130.Suppl_1.2714.2714

Published: 2017

Journal Articles

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa A. Kuzmina, MD PhD, Galina Baskhaeva, MD, Kseniia Zarubina, MD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 2805.

https://doi.org/10.1182/blood.V128.22.2805.2805

Published: 2016

Journal Articles

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Nikolay M Kapranov, Yuliya O Davydova, Nataliya Petinati, PhD, Maria V Bakshinskayte, Irina V Galtseva, Nina I. Drize, PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G Savchenko, PhD MD

Blood (2016) 128 (22): 5722.

https://doi.org/10.1182/blood.V128.22.5722.5722

Published: 2016

Journal Articles

Substantial Variation in Nlv-Specific T Cells Phenotype and Activation Ability upon Antigen Stimulation May Have Implications for Virus-Specific Adoptive Therapy

Grigory A. Efimov, MD, PhD, Alexander S. Vdovin, Filkin Y. Sergei, Polina R. Yefimova, Savely A. Sheetikov, Mikhail Yu. Drokov, MD PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 5725.

https://doi.org/10.1182/blood.V128.22.5725.5725

Published: 2016

Journal Articles

Molecular and Biological Characteristics of Tumour Substrate in Patients with Extramedullary Multiple Myeloma

Maya V. Firsova, MD, Larisa P. Mendeleeva, MD PhD Prof, Alla M. Kovrigina, MD PhD, Natalia L. Deineko, MD, Maxim V. Solovev, MD PhD, Maria V. Nareyko, MD, Larisa A. Kuzmina, MD PhD, Valery G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 5642.

https://doi.org/10.1182/blood.V128.22.5642.5642

Published: 2016

Journal Articles

Neuropsychological Impairments in Hematological Malignancies Patients Expected to Allo-BMT

Dmitry E Vybornykh, MD PhD Dr.scient.MD, Sergey O Khrushchev, Svetlana Yu Fedorova, Alexander Tkhostov, Ilia V Pluzhnikov, PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5807.

https://doi.org/10.1182/blood.V128.22.5807.5807

Published: 2016

NARROW

Non-Intensive Continuous Treatment with a Tyrosine Kinase Inhibitor (TKI) Followed By Allo-HSCT Is an Effective Therapeutic Strategy for Adult Ph-Positive Acute Lymphoblastic Leukemia: Outcomes of the Russian Prospective Multicenter RALL Study

Dynamics of Cytokines Concentration in the Blood Plasma of Patients after Multipotent Mesenchymal Stromal Cells Administration for Graft Versus Host Disease Prevention

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy

Chemotherapy Related Neuropsychological Changes in Patients with Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia

Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Intraosseous Administration of Multipotent Mesenchymal Stromal Cells to Patients with Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation

Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Substantial Variation in Nlv-Specific T Cells Phenotype and Activation Ability upon Antigen Stimulation May Have Implications for Virus-Specific Adoptive Therapy

Molecular and Biological Characteristics of Tumour Substrate in Patients with Extramedullary Multiple Myeloma

Neuropsychological Impairments in Hematological Malignancies Patients Expected to Allo-BMT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only